Access cutting-edge diabetic retinopathy treatment through this clinical trial at a research site in Elmhurst. Study-provided care at no cost to qualified participants.
Access diabetic retinopathy specialists in Elmhurst at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic retinopathy treatment provided free
The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatment for Diabetic Retinopathy of Non-Proliferative Type (NPDR). The primary objective of the study is to evaluate the efficacy of daily oral doses of VX-01 versus placebo following 52 weeks of treatment.
Sponsor: Vantage Biosciences Ltd
Check if you qualify for this diabetic retinopathy clinical trial in Elmhurst, IL
If you're searching for diabetic retinopathy treatment options in Elmhurst, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Elmhurst research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic retinopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.